160039 Investors following SBI. Share this News with them.
0
Like this story, share it with millions of investors on M3
Brokers bullish on SBI, Cairn India, Glaxo Pharma
Brokerage houses are bullish on SBI, Cairn India, Glaxo Pharma, ICICI Bank, Tata Power, Bank Of India and M&M.
Goldman Sachs has kept sell rating on ONGC, with price target Rs 625
Sharekhan has kept buy rating on SBI, with price target Rs 1801
CLSA has kept buy rating on SBI, with price target Rs 1650
CLSA has kept buy rating on Cairn India, with price target Rs 290
Motilal Oswal Sec has kept buy rating on Glaxo Pharma, with price target Rs 1392
Motilal Oswal Sec has kept buy rating on ICICI Bank, with price target Rs 581
Kotak Institution has kept reduce on NTPC, with price target Rs 160
Kotak Institution has upgraded SBI to buy rating, with price target Rs 1600
Kotak Institution has kept buy rating on Tata Power, with price target Rs 1275
Emkay has kept buy rating on Bank Of India, with price target Rs 340
Citi has kept sell rating on Tata Tele, with price target Rs 12
Citi has kept buy rating on M&M, with price target Rs 447
House |
Stocks |
Views |
|
Goldman Sachs |
ONGC |
Sell; with price target Rs 625 |
|
Sharekhan |
SBI |
Buy; with price target Rs 1801 |
|
CLSA |
SBI
Cairn India |
Buy; with price target Rs 1650
Buy; with price target Rs 290 |
|
Motilal Oswal Sec |
Glaxo Pharma
ICICI Bank |
Buy; with price target Rs 1392
Buy; with price target Rs 581 |
|
Kotak Institution |
NTPC
SBI
Tata Power |
Reduce; with price target Rs 160
Buy; with price target Rs 1600
Buy; with price target Rs 1275
|
|
Emkay |
Bank Of India |
Buy; with price target Rs 340 |
|
Citi |
Tata Tele
M&M |
Sell; with price target Rs 12
Buy; with price target Rs 447 |